Persistent Pulmonary Hypertension of the Newborn Management: Mechanistic Rationale, Comparative Evidence, and Resource-Adapted Use

Authors

  • Hala Mohammed Amin Abdelmoneim, Ehab Abdelmoniem Youseef Albanna, Saed M Morsy , Ahmed Mohamed Abdullah Author

DOI:

https://doi.org/10.48047/r3jx2e11

Keywords:

persistent pulmonary hypertension of the newborn; sildenafil; magnesium sulfate; pulmonary vasodilators; neonatal intensive care

Abstract

Background: Persistent pulmonary hypertension of the newborn (PPHN) causes extrapulmonary right-to-left shunting and hypoxemic respiratory failure. Incomplete response and restricted access to inhaled nitric oxide have encouraged the use of sildenafil and magnesium sulfate. 

Downloads

Download data is not yet available.

References

Chojnacka K, Singh Y, Gahlaut S, Blaz W, Jerzak A, Szczapa T. Persistent pulmonary hypertension of the newborn: a pragmatic review of pathophysiology, diagnosis, and advances in management. Biomedicines. 2025;13(10):2332.

Mandell E, Kinsella JP, Abman SH. Persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 2021;56(3):661-669

Downloads

Published

2024-11-20

How to Cite

Persistent Pulmonary Hypertension of the Newborn Management: Mechanistic Rationale, Comparative Evidence, and Resource-Adapted Use (Hala Mohammed Amin Abdelmoneim, Ehab Abdelmoniem Youseef Albanna, Saed M Morsy , Ahmed Mohamed Abdullah , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 8426-8436. https://doi.org/10.48047/r3jx2e11